These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 573772)

  • 21. The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction.
    Miller SD; Claman HN
    J Immunol; 1976 Nov; 117(5 Pt 1):1519-26. PubMed ID: 1087316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the immune response to altered self induced by immunogenic and nonimmunogenic altered self structures.
    Ramos T; Möller E; Möller G
    Eur J Immunol; 1980 Feb; 10(2):100-4. PubMed ID: 6989616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on lymphocyte-mediated cytolysis. XII. Hapten transferred to cell surfaces by interaction with liposomes is recognized by antibody but not by hapten-specific H-2 restricted cytotoxic T cells.
    Ozato K; Henney CS
    J Immunol; 1978 Dec; 121(6):2405-12. PubMed ID: 102694
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-hapten antibody in primary immune antiserum can specifically inhibit antibody-secreting cells.
    Woodland RT; Zimmerman DM; Schrater AF
    J Immunol; 1982 Nov; 129(5):2009-15. PubMed ID: 6749983
    [No Abstract]   [Full Text] [Related]  

  • 25. Murine immunogenicity of N-substituted phosphatidylethanolamine derivatives in liposomes: response to the hapten phosphocholine.
    Honegger JL; Isakson PC; Kinsky SC
    J Immunol; 1980 Feb; 124(2):669-75. PubMed ID: 6985935
    [No Abstract]   [Full Text] [Related]  

  • 26. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
    J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular mechanism of primary anti-Thy-1 antibody responses in vitro induced by uniquely immunogenic thymocyte antigens.
    Isobe KI; Nakashima I; Nagase F; Kato N; Mizoguchi K; Kawashima K; Lake P
    J Immunol; 1984 Mar; 132(3):1100-5. PubMed ID: 6141204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of tolerance by haptenated liposomes carrying mouse erythrocyte membrane glycoprotein.
    Hitsumoto Y; Hineno T; Utsumi S
    Immunology; 1984 Dec; 53(4):847-54. PubMed ID: 6209210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. XIII. Characterization of a third T cell population involved in suppression of in vitro PFC responses.
    Sherr DH; Dorf ME
    J Immunol; 1982 Mar; 128(3):1260-6. PubMed ID: 6173430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hapten-specific murine colony-forming B cells: in vitro response of colonies to fluoresceinated thymus independent antigens.
    Pillai PS; Scott DW
    J Immunol; 1981 May; 126(5):1883-6. PubMed ID: 6163821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific suppression of anti-hapten reaginic antibody titers with hapten-coated liposomes.
    Schwenk R; Lee WY; Sehon AH
    J Immunol; 1978 May; 120(5):1612-5. PubMed ID: 659865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific targeting of phototoxic haptenated liposomes to a hapten-specific B cell lymphoma.
    Avrilionis K; Boggs JM
    Cell Immunol; 1996 Feb; 168(1):13-23. PubMed ID: 8599835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A reappraisal of "T-independent" antigens. I. Effect of lymphokines on the response of single adult hapten-specific B lymphocytes.
    Pike BL; Nossal GJ
    J Immunol; 1984 Apr; 132(4):1687-95. PubMed ID: 6199407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of liposome-induced humoral immune responses by non-ionic block polymer surfactants in Xid mice.
    Zigterman GJ; Jansze M; Snippe H; Willers JM
    Immunology; 1988 Sep; 65(1):37-42. PubMed ID: 3053425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of hapten-specific antibody-forming cell precursors in microcultures.
    Stocker JW
    Immunology; 1976 Feb; 30(2):181-7. PubMed ID: 770314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulation with liposomes: the immune response elicited by liposomes with entrapped dichloromethylene-diphosphonate and surface-associated antigen or hapten.
    Claassen E; Kors N; van Rooijen N
    Immunology; 1987 Apr; 60(4):509-15. PubMed ID: 2953668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of self carriers in the immune response and tolerance. X. A lymphoid dendritic-like tumor, P388AD.2, acts as a novel immunogenic carrier for hapten.
    Cogswell JP; Phipps RP; Scott DW
    J Immunol; 1986 Aug; 137(3):777-83. PubMed ID: 3522737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the immunogenicity and tolerogenicity of T-independent antigens.
    Dintzis RZ; Middleton MH; Dintzis HM
    J Immunol; 1983 Nov; 131(5):2196-203. PubMed ID: 6631009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
    Moser G; Burakoff SJ; Abbas AK
    J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An alternative procedure for the preparation of immunogenic liposomal model membranes.
    Kinsky SC; Loader JE; Benson AL
    J Immunol Methods; 1983 Dec; 65(3):295-306. PubMed ID: 6418820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.